Skip to main content
. 2011 Dec 19;119(6):1428–1439. doi: 10.1182/blood-2011-07-366781

Table 1.

Clinical features of GT and PEG-ADA treated patients at the time of analysis

Patients Age, y Follow-up, y Autoimmunity T cells, counts/μL
dAXP, μmol
CD3 CD4
GT (n = 11) 4.5 (1.5-10.8) 3 (1-8.5) 1 patient with hypothyroidism 848 (452-2911) 410 (121-709) 15 (0-84)
PEG-ADA (n = 7) 12.1 (0.6-23) 13 (0.5-21.2) 1 patient with type I diabetes 1489 (71-4599) 671 (35-1653) 4 (0-74)

Data are median (range).

dAXP indicates deoxyadenosine nucleotides in RBCs.

HHS Vulnerability Disclosure